Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

CCDC13 Inhibitors

CCDC13, or Coiled-Coil Domain Containing 13, is a protein encoded by the CCDC13 gene in humans. As suggested by the nomenclature, this protein is characterized by the presence of a coiled-coil domain, which is a structure that facilitates the oligomerization of proteins and their interactions with other molecules. Such domains are instrumental in the formation of stable, multi-protein complexes, essential for a variety of cellular functions including structural support, motility, and intracellular transport.The specific role of CCDC13 in cellular processes is not thoroughly defined. However, proteins with coiled-coil domains are often involved in the dynamics of cytoskeletal organization, vesicular trafficking, chromosomal segregation during cell division, and the transduction of signals within the cellular environment. By inference, CCDC13 may contribute to one or several of these processes, possibly engaging in interactions that are crucial for maintaining cellular integrity or for orchestrating complex cellular events.

The subcellular localization of CCDC13 could offer additional insights into its function. If it localizes to specific organelles or structures within the cell, such as the nucleus, centrosomes, or cytoskeletal elements, this could hint at a role in processes like gene expression regulation, cell cycle progression, or structural assembly.Alterations in the CCDC13 gene, including mutations or changes in expression levels, could be associated with pathological states, especially if the protein is involved in critical cellular processes. Determining the expression patterns of CCDC13-whether it is ubiquitous or restricted to certain tissues-could also be indicative of its functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, might indirectly affect CCDC13 by modulating cellular growth and autophagy processes, potentially influencing proteins involved in these pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, can affect various signaling pathways, potentially altering the expression or function of proteins like CCDC13 involved in cellular processes regulated by PI3K.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, by inhibiting p38 MAPK, could indirectly influence CCDC13 function, as p38 MAPK is key in inflammatory responses and stress-induced pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, may alter CCDC13-related pathways by affecting cellular processes like growth, survival, and metabolism.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059, an inhibitor of MEK, may indirectly modulate CCDC13 activity by influencing the MAPK/ERK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, might affect CCDC13 indirectly by modulating cellular stress responses and apoptosis pathways.

LY3214996

1951483-29-6sc-507299
5 mg
$265.00
(0)

LY3214996, an ERK1/2 inhibitor, potentially impacts CCDC13 indirectly by modulating signaling pathways involved in cell proliferation and differentiation.

Torin 1

1222998-36-8sc-396760
10 mg
$245.00
7
(1)

Torin 1, an mTOR inhibitor like Rapamycin, can indirectly affect the function or expression of CCDC13 by altering cellular growth and autophagy pathways.

BIX 02189

1094614-85-3sc-364436
sc-364436A
5 mg
10 mg
$224.00
$386.00
5
(1)

BIX 02189, a MEK5 inhibitor, might indirectly influence CCDC13 through pathways involving the ERK5/MAPK7 cascade.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

Selumetinib, a MEK inhibitor, could indirectly affect CCDC13 by modulating the MAPK/ERK pathway, impacting cell growth and differentiation.